Cloned (Comment) | Organism |
---|---|
gene murI, recombinant expression of His-tagged enzyme in Escherichia coli strain BL21(DE3) | Mycobacterium tuberculosis |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
1-(3-(5-methylbenzo[d]oxazol-2-yl)phenyl)-3-(4-nitrophenyl)thiourea | - |
Mycobacterium tuberculosis | |
1-(3-(5-methylbenzo[d]oxazol-2-yl)phenyl)-3-(p-tolyl)thiourea | - |
Mycobacterium tuberculosis | |
1-(3-(5-methylbenzo[d]oxazol-2-yl)phenyl)-3-phenylthiourea | - |
Mycobacterium tuberculosis | |
1-(3-(5-methylbenzo[d]oxazol-2-yl)phenyl)-3-phenylurea | - |
Mycobacterium tuberculosis | |
1-(3-(benzo[d]oxazol-2-yl)phenyl)-3-(4-chlorophenyl)thiourea | - |
Mycobacterium tuberculosis | |
1-(3-(benzo[d]oxazol-2-yl)phenyl)-3-(4-chlorophenyl)urea | - |
Mycobacterium tuberculosis | |
1-(3-(benzo[d]oxazol-2-yl)phenyl)-3-(4-fluorophenyl)thiourea | - |
Mycobacterium tuberculosis | |
1-(3-(benzo[d]oxazol-2-yl)phenyl)-3-(4-fluorophenyl)urea | - |
Mycobacterium tuberculosis | |
1-(3-(benzo[d]oxazol-2-yl)phenyl)-3-(4-methoxyphenyl)urea | - |
Mycobacterium tuberculosis | |
1-(3-(benzo[d]oxazol-2-yl)phenyl)-3-(4-nitrophenyl)thiourea | - |
Mycobacterium tuberculosis | |
1-(3-(benzo[d]oxazol-2-yl)phenyl)-3-(4-nitrophenyl)urea | - |
Mycobacterium tuberculosis | |
1-(3-(benzo[d]oxazol-2-yl)phenyl)-3-(p-tolyl)thiourea | - |
Mycobacterium tuberculosis | |
1-(3-(benzo[d]oxazol-2-yl)phenyl)-3-(p-tolyl)urea | - |
Mycobacterium tuberculosis | |
1-(3-(benzo[d]oxazol-2-yl)phenyl)-3-benzylthiourea | - |
Mycobacterium tuberculosis | |
1-(3-(benzo[d]oxazol-2-yl)phenyl)-3-benzylurea | - |
Mycobacterium tuberculosis | |
1-(3-(benzo[d]oxazol-2-yl)phenyl)-3-isopropylurea | - |
Mycobacterium tuberculosis | |
1-(3-(benzo[d]oxazol-2-yl)phenyl)-3-phenylthiourea | - |
Mycobacterium tuberculosis | |
1-(3-(benzo[d]oxazol-2-yl)phenyl)-3-phenylurea | - |
Mycobacterium tuberculosis | |
1-(4-chlorophenyl)-3-(3-(5-methylbenzo[d]oxazol-2-yl)phenyl)thiourea | Binding pose and the interaction pattern of the compound, non-competitive inhibition | Mycobacterium tuberculosis | |
1-(4-chlorophenyl)-3-(3-(5-methylbenzo[d]oxazol-2-yl)phenyl)urea | - |
Mycobacterium tuberculosis | |
1-(4-fluorophenyl)-3-(3-(5-methylbenzo[d]oxazol-2-yl)phenyl)thiourea | - |
Mycobacterium tuberculosis | |
1-(4-fluorophenyl)-3-(3-(5-methylbenzo[d]oxazol-2-yl)phenyl)urea | - |
Mycobacterium tuberculosis | |
1-(4-methoxyphenyl)-3-(3-(5-methylbenzo[d]oxazol-2-yl)phenyl)urea | - |
Mycobacterium tuberculosis | |
1-benzyl-3-(3-(5-methylbenzo[d]oxazol-2-yl)phenyl)thiourea | - |
Mycobacterium tuberculosis | |
3-(5-methylbenzo[d]oxazol-2-yl)aniline | - |
Mycobacterium tuberculosis | |
3-(benzo[d]oxazol-2-yl)aniline | - |
Mycobacterium tuberculosis | |
additional information | development of a class of Mycobacterium tuberculosis (Mtb) inhibitors by exploring the pharmaceutically underexploited enzyme targets which are majorly involved in cell wall biosynthesis of mycobacteria, compoud library screening using a thermal shift assay. Identification of two lead compounds, optimization and expansion result in twenty four compounds. Molecular docking and dynamic studies using the D-glutamate bound glutamate racemase structures of Mycobacterium tuberculosis (PDB ID 5HJ7) and Bacillus subtilis (PDB ID 1ZUW), simulations and modeling, overview. The compounds are also tested on their cytotoxicity and in a Myconacterium tuberculosis biofilm assay, activity profile of compounds in nutrient starved stress model, overview | Mycobacterium tuberculosis | |
N-benzyl-N'-[3-(5-methyl-1,3-benzoxazol-2-yl)phenyl]urea | - |
Mycobacterium tuberculosis |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
L-glutamate | Mycobacterium tuberculosis | - |
D-glutamate | - |
r | |
L-glutamate | Mycobacterium tuberculosis ATCC 25618 / H37Rv | - |
D-glutamate | - |
r |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Mycobacterium tuberculosis | P9WPW9 | - |
- |
Mycobacterium tuberculosis ATCC 25618 / H37Rv | P9WPW9 | - |
- |
Purification (Comment) | Organism |
---|---|
gene murI, recombinant expression of His-tagged enzyme from Escherichia coli strain BL21(DE3) by nickel affinity chromatography | Mycobacterium tuberculosis |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
L-glutamate | - |
Mycobacterium tuberculosis | D-glutamate | - |
r | |
L-glutamate | - |
Mycobacterium tuberculosis ATCC 25618 / H37Rv | D-glutamate | - |
r |
Synonyms | Comment | Organism |
---|---|---|
MurI | - |
Mycobacterium tuberculosis |
Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|
37 | - |
assay at | Mycobacterium tuberculosis |
pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|
8 | - |
assay at | Mycobacterium tuberculosis |
IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|
0.0011 | - |
pH 8.0, 37°C, recombinant enzyme | Mycobacterium tuberculosis | 1-(3-(benzo[d]oxazol-2-yl)phenyl)-3-(4-fluorophenyl)thiourea | |
0.0013 | - |
pH 8.0, 37°C, recombinant enzyme | Mycobacterium tuberculosis | 1-(3-(benzo[d]oxazol-2-yl)phenyl)-3-benzylthiourea | |
0.00182 | - |
pH 8.0, 37°C, recombinant enzyme | Mycobacterium tuberculosis | 1-(3-(benzo[d]oxazol-2-yl)phenyl)-3-(4-fluorophenyl)urea | |
0.0044 | - |
pH 8.0, 37°C, recombinant enzyme | Mycobacterium tuberculosis | 1-(3-(benzo[d]oxazol-2-yl)phenyl)-3-(4-nitrophenyl)thiourea | |
0.00625 | - |
pH 8.0, 37°C, recombinant enzyme | Mycobacterium tuberculosis | N-benzyl-N'-[3-(5-methyl-1,3-benzoxazol-2-yl)phenyl]urea | |
0.0068 | - |
pH 8.0, 37°C, recombinant enzyme | Mycobacterium tuberculosis | 1-(3-(5-methylbenzo[d]oxazol-2-yl)phenyl)-3-(4-nitrophenyl)thiourea | |
0.007 | - |
pH 8.0, 37°C, recombinant enzyme | Mycobacterium tuberculosis | 3-(5-methylbenzo[d]oxazol-2-yl)aniline | |
0.00712 | - |
pH 8.0, 37°C, recombinant enzyme | Mycobacterium tuberculosis | 1-(3-(benzo[d]oxazol-2-yl)phenyl)-3-isopropylurea | |
0.00835 | - |
pH 8.0, 37°C, recombinant enzyme | Mycobacterium tuberculosis | 1-(3-(benzo[d]oxazol-2-yl)phenyl)-3-(p-tolyl)urea | |
0.0085 | - |
pH 8.0, 37°C, recombinant enzyme | Mycobacterium tuberculosis | 1-(4-fluorophenyl)-3-(3-(5-methylbenzo[d]oxazol-2-yl)phenyl)urea | |
0.0088 | - |
pH 8.0, 37°C, recombinant enzyme | Mycobacterium tuberculosis | 1-(3-(5-methylbenzo[d]oxazol-2-yl)phenyl)-3-phenylthiourea | |
0.0115 | - |
pH 8.0, 37°C, recombinant enzyme | Mycobacterium tuberculosis | 1-(3-(benzo[d]oxazol-2-yl)phenyl)-3-(4-chlorophenyl)urea | |
0.0228 | - |
pH 8.0, 37°C, recombinant enzyme | Mycobacterium tuberculosis | 1-(4-fluorophenyl)-3-(3-(5-methylbenzo[d]oxazol-2-yl)phenyl)thiourea | |
0.025 | - |
above, pH 8.0, 37°C, recombinant enzyme | Mycobacterium tuberculosis | 1-(3-(5-methylbenzo[d]oxazol-2-yl)phenyl)-3-(p-tolyl)thiourea | |
0.025 | - |
above, pH 8.0, 37°C, recombinant enzyme | Mycobacterium tuberculosis | 1-(3-(5-methylbenzo[d]oxazol-2-yl)phenyl)-3-phenylurea | |
0.025 | - |
above, pH 8.0, 37°C, recombinant enzyme | Mycobacterium tuberculosis | 1-(3-(benzo[d]oxazol-2-yl)phenyl)-3-(4-chlorophenyl)thiourea | |
0.025 | - |
above, pH 8.0, 37°C, recombinant enzyme | Mycobacterium tuberculosis | 1-(3-(benzo[d]oxazol-2-yl)phenyl)-3-(4-methoxyphenyl)urea | |
0.025 | - |
above, pH 8.0, 37°C, recombinant enzyme | Mycobacterium tuberculosis | 1-(3-(benzo[d]oxazol-2-yl)phenyl)-3-(4-nitrophenyl)urea | |
0.025 | - |
above, pH 8.0, 37°C, recombinant enzyme | Mycobacterium tuberculosis | 1-(3-(benzo[d]oxazol-2-yl)phenyl)-3-(p-tolyl)thiourea | |
0.025 | - |
above, pH 8.0, 37°C, recombinant enzyme | Mycobacterium tuberculosis | 1-(3-(benzo[d]oxazol-2-yl)phenyl)-3-benzylurea | |
0.025 | - |
above, pH 8.0, 37°C, recombinant enzyme | Mycobacterium tuberculosis | 1-(3-(benzo[d]oxazol-2-yl)phenyl)-3-phenylthiourea | |
0.025 | - |
above, pH 8.0, 37°C, recombinant enzyme | Mycobacterium tuberculosis | 1-(3-(benzo[d]oxazol-2-yl)phenyl)-3-phenylurea | |
0.025 | - |
above, pH 8.0, 37°C, recombinant enzyme | Mycobacterium tuberculosis | 1-(4-chlorophenyl)-3-(3-(5-methylbenzo[d]oxazol-2-yl)phenyl)thiourea | |
0.025 | - |
above, pH 8.0, 37°C, recombinant enzyme | Mycobacterium tuberculosis | 1-(4-chlorophenyl)-3-(3-(5-methylbenzo[d]oxazol-2-yl)phenyl)urea | |
0.025 | - |
above, pH 8.0, 37°C, recombinant enzyme | Mycobacterium tuberculosis | 1-(4-methoxyphenyl)-3-(3-(5-methylbenzo[d]oxazol-2-yl)phenyl)urea | |
0.025 | - |
above, pH 8.0, 37°C, recombinant enzyme | Mycobacterium tuberculosis | 1-benzyl-3-(3-(5-methylbenzo[d]oxazol-2-yl)phenyl)thiourea | |
0.025 | - |
above, pH 8.0, 37°C, recombinant enzyme | Mycobacterium tuberculosis | 3-(benzo[d]oxazol-2-yl)aniline |
General Information | Comment | Organism |
---|---|---|
metabolism | glutamate racemase racemizes D-glutamate from L-glutamate, a key step in peptidoglycan synthesis | Mycobacterium tuberculosis |
physiological function | glutamate racemase racemizes D-glutamate from L-glutamate, a key step in peptidoglycan synthesis | Mycobacterium tuberculosis |